Abstract:Type 1 diabetes mellitus (T1DM) is a chronic immunemediated disease that specifically targets insulin-producing pancreatic b cells. Atopic dermatitis (AD) or eczema is a polyfactorial chronic relapsing inflammatory/autoimmune disease with a major impact on quality of life that has been often associated with other comorbidities. Both diseases have a mainly childhood onset. However, although both diseases are considered to be immune-mediated, AD is driven by T-helper (Th) 2-dependent inflammation, whereas T1DM is mediated mainly by a Th1 response; these two pathways being theoretically mutually inhibitory. In this issue of the BJD, Lin et al. propose a populationbased, retrospective cohort study, the main aim of which was to analyse the association between T1DM and AD using claims data from the National Health Insurance program of Taiwan. They identified 3386 patients with T1DM newly diagnosed from 1998 to 2011 and 12 725 randomly selected controls without T1DM. The 12 725 controls were matched by age, sex and year of diagnosis. All patients were followed up until the end of 2011 and AD was notified if it developed. Both cohorts were compared using Cox proportional hazards regression models to analyse the risk of AD. The main result of this study is that the overall incidence rate of AD was significantly higher in the T1DM cohort than in the non-T1DM cohort even after adjustment for potential risk factors. However, the AD incidence densities were shown to be very low in both groups (fewer than three new patients with AD per 1000 patient-years). This finding may be due to the high mean age (11 years) of the children in both cohorts. Indeed, most patients with AD have usually been diagnosed before this age. In addition, the authors showed that among patients with T1DM, only those with more emergency room visits or hospitalizations had a higher risk of subsequent AD compared with the non-T1DM cohort. This latter finding may raise the possibility of a surveillance bias in the T1DM cohort, as children with more hospitalizations undergo more clinical followup. In the past, the association of AD and T1DM has drawn conflicting results and to date no other study has found a significant association between these two diseases. Although the validity of the results may be restricted to Chinese ethnic groups, the strength of the study by Lin et al. is that this is the first nationwide study that has been performed to examine this association. The apparent and oversimplified antagonism between these two diseases, i.e. AD is driven by Th2-dependent inflammation whereas T1DM is mediated mainly by a Th1 response, may reflect the complexity of deciphering the immune pathways in autoimmune/autoinflammatory diseases. Moreover, it is probable that different endophenotypes exist within the spectrum of AD and T1DM, which may have different immune pathways and add to the complexity of the pathophysiological picture underlying these diseases. Further prospective studies taking into account the different endophenotypes/stages of both diseases and more potential confounding factors are thus needed to confirm this association.

Procainamide-induced autoimmunity: Relationship to T-helper 2-type T-cell activation

Cellular and Molecular Mechanisms of Autoimmune Disease

Therapeutic Effects of Procainamide on Endotoxin-Induced Rhabdomyolysis in Rats

Clinical and histopathologic features of drug-induced autoimmune hepatitis

Drug-induced immune hemolytic anemia: the last 30 years of changes

HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment

Immune hemolytic anemia caused by drugs

Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity

Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses

Features of Autoimmune Hepatitis in Patients with Drug-induced Liver Injury

Inflammasomes and human autoimmunity: A comprehensive review

Influence of lupus-induced drugs on immune functions of mice

Basal Cell Carcinoma in Organ Transplant Recipients

Delayed drug hypersensitivity reactions: How p-i transforms pharmacology into immunology

Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations

The role of amino acid metabolism in autoimmune hepatitis

Nanoparticle-Based Drug Delivery Systems for Induction of Tolerance and Treatment of Autoimmune Diseases

Elucidating the causal nexus between antibody-mediated immunity and autoimmune diseases: Insights from bidirectional mendelian randomization, gene expression profiling, and drug sensitivity analysis

Antigen-specific T cell responses in autoimmune diabetes

Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007

Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis